Section Arrow
GRFS.NASDAQ
- Grifols SA
Quotes are at least 15-min delayed:2026/04/25 05:36 EDT
Regular Hours
Last
 8.08
+0.09 (+1.13%)
Day High 
8.12 
Prev. Close
7.99 
1-M High
8.83 
Volume 
343.91K 
Bid
7.86
Ask
8.26
Day Low
7.97 
Open
8.08 
1-M Low
7.39 
Market Cap 
5.44B 
Currency 美元 
P/E 11.59 
%Yield 2.18 
10-SMA 8.44 
20-SMA 8.22 
50-SMA 8.45 
52-W High 11.14 
52-W Low 6.9 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
0.59/1.00
Enterprise Value
14.48B
Balance Sheet
Book Value Per Share
9.13
Cash Flow
Cash Flow Yield
0.23
Income Statement
Total Revenue
7.52B
Operating Revenue Per Share
10.16
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
PFEPfizer27+0.33+1.24%19.61PE
OGNOrganon & Co11.26+2.66+30.93%11.87PE
NVONovo-Nordisk A/S41.17+2.65+6.88%10.72PE
ABBVABBVIE198.71-2.24-1.11%84.84PE
MRKMerck & Co111.9-2.72-2.37%15.67PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses onproducts derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.